Intercept Pharmaceuticals
ICPT
#6665
Rank
A$1.17 B
Marketcap
A$28.21
Share price
0.00%
Change (1 day)
-11.22%
Change (1 year)

Earnings for Intercept Pharmaceuticals (ICPT)

Earnings in 2023 (TTM): -A$86.42 Million

According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings are A$0.31 Billion. In 2022 the company made an earning of -A$0.24 Billion a decrease over its 2021 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intercept Pharmaceuticals from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$86.42 Million-63.45%
2022 -A$0.24 Billion74.17%
2021 -A$0.14 Billion-66.74%
2020 -A$0.41 Billion-20.25%
2019 -A$0.52 Billion11.46%
2018 -A$0.46 Billion-14.19%
2017 -A$0.54 Billion-12.71%
2016 -A$0.62 Billion82.32%
2015 -A$0.34 Billion-23.21%
2014 -A$0.44 Billion334.95%
2013 -A$0.11 Billion60.48%
2012 -A$62.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$51.62 B-60,036.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.77 Billion 4,266.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.82 B-19,634.56%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.96 Million-81.47%๐Ÿ‡บ๐Ÿ‡ธ USA